In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases

Overview

Journal PLoS Genet

Specialty Genetics

Date 2012 Jul 5

PMID 22761581

Citations 205

Authors

Julia Arand

David Spieler

Tommy Karius

Miguel R Branco

Daniela Meilinger

Alexander Meissner

Thomas Jenuwein

Guoliang Xu

Heinrich Leonhardt

Verena Wolf

Jorn Walter

Affiliations

Soon will be listed here.

Abstract

The enzymatic control of the setting and maintenance of symmetric and non-symmetric DNA methylation patterns in a particular genome context is not well understood. Here, we describe a comprehensive analysis of DNA methylation patterns generated by high resolution sequencing of hairpin-bisulfite amplicons of selected single copy genes and repetitive elements (LINE1, B1, IAP-LTR-retrotransposons, and major satellites). The analysis unambiguously identifies a substantial amount of regional incomplete methylation maintenance, i.e. hemimethylated CpG positions, with variant degrees among cell types. Moreover, non-CpG cytosine methylation is confined to ESCs and exclusively catalysed by Dnmt3a and Dnmt3b. This sequence position-, cell type-, and region-dependent non-CpG methylation is strongly linked to neighboring CpG methylation and requires the presence of Dnmt3L. The generation of a comprehensive data set of 146,000 CpG dyads was used to apply and develop parameter estimated hidden Markov models (HMM) to calculate the relative contribution of DNA methyltransferases (Dnmts) for de novo and maintenance DNA methylation. The comparative modelling included wild-type ESCs and mutant ESCs deficient for Dnmt1, Dnmt3a, Dnmt3b, or Dnmt3a/3b, respectively. The HMM analysis identifies a considerable de novo methylation activity for Dnmt1 at certain repetitive elements and single copy sequences. Dnmt3a and Dnmt3b contribute de novo function. However, both enzymes are also essential to maintain symmetrical CpG methylation at distinct repetitive and single copy sequences in ESCs.

Citing Articles

The Role of the DNA Methyltransferase Family and the Therapeutic Potential of DNMT Inhibitors in Tumor Treatment.

Kim D Curr Oncol. 2025; 32(2).

PMID: 39996888 PMC: 11854558. DOI: 10.3390/curroncol32020088.

Modeling DNA methyltransferase function to predict epigenetic correlation patterns in healthy and cancer cells.

Tse A, Spakowitz A Proc Natl Acad Sci U S A. 2025; 122(2):e2415530121.

PMID: 39792289 PMC: 11745332. DOI: 10.1073/pnas.2415530121.

Setdb1 and Atf7IP form a hetero-trimeric complex that blocks Setdb1 nuclear export.

Kariapper L, Marathe I, Niesman A, Suino-Powell K, Chook Y, Wysocki V bioRxiv. 2025; .

PMID: 39764026 PMC: 11703210. DOI: 10.1101/2024.12.23.630145.

Role of DNA methylation transferase in urinary system diseases: From basic to clinical perspectives (Review).

Yang Y, Wang Y, Fan X, Xu X, Wang H, Wang X Int J Mol Med. 2024; 55(2).

PMID: 39575487 PMC: 11611324. DOI: 10.3892/ijmm.2024.5460.

The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).

Mohd Kamal K, Ghazali A, Ab Mutalib N, Abu N, Chua E, Masre S Heliyon. 2024; 10(19):e38663.

PMID: 39403460 PMC: 11472108. DOI: 10.1016/j.heliyon.2024.e38663.

References

Su A, Wiltshire T, Batalov S, Lapp H, Ching K, Block D . A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004; 101(16):6062-7. PMC: 395923. DOI: 10.1073/pnas.0400782101. View

Nestor C, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D . Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2011; 22(3):467-77. PMC: 3290782. DOI: 10.1101/gr.126417.111. View

Lister R, Pelizzola M, Dowen R, Hawkins R, Hon G, Tonti-Filippini J . Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009; 462(7271):315-22. PMC: 2857523. DOI: 10.1038/nature08514. View

Lister R, Pelizzola M, Kida Y, Hawkins R, Nery J, Hon G . Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011; 471(7336):68-73. PMC: 3100360. DOI: 10.1038/nature09798. View

Frauer C, Hoffmann T, Bultmann S, Casa V, Cardoso M, Antes I . Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS One. 2011; 6(6):e21306. PMC: 3120858. DOI: 10.1371/journal.pone.0021306. View

Pfeifer G, Steigerwald S, Hansen R, Gartler S, Riggs A . Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc Natl Acad Sci U S A. 1990; 87(21):8252-6. PMC: 54933. DOI: 10.1073/pnas.87.21.8252. View

Yoder J, Walsh C, Bestor T . Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997; 13(8):335-40. DOI: 10.1016/s0168-9525(97)01181-5. View

Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo T . The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007; 450(7171):908-12. DOI: 10.1038/nature06397. View

Kriaucionis S, Heintz N . The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009; 324(5929):929-30. PMC: 3263819. DOI: 10.1126/science.1169786. View

10.

Gowher H, Jeltsch A . Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J Mol Biol. 2001; 309(5):1201-8. DOI: 10.1006/jmbi.2001.4710. View

11.

Gama-Sosa M, Midgett R, Slagel V, Githens S, KUO K, GEHRKE C . Tissue-specific differences in DNA methylation in various mammals. Biochim Biophys Acta. 1983; 740(2):212-9. DOI: 10.1016/0167-4781(83)90079-9. View

12.

Li E, Bestor T, Jaenisch R . Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992; 69(6):915-26. DOI: 10.1016/0092-8674(92)90611-f. View

13.

Vilkaitis G, Suetake I, Klimasauskas S, Tajima S . Processive methylation of hemimethylated CpG sites by mouse Dnmt1 DNA methyltransferase. J Biol Chem. 2004; 280(1):64-72. DOI: 10.1074/jbc.M411126200. View

14.

Lorincz M, Schubeler D, Hutchinson S, Dickerson D, Groudine M . DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol Cell Biol. 2002; 22(21):7572-80. PMC: 135678. DOI: 10.1128/MCB.22.21.7572-7580.2002. View

15.

Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong C . Dynamic changes in the human methylome during differentiation. Genome Res. 2010; 20(3):320-31. PMC: 2840979. DOI: 10.1101/gr.101907.109. View

16.

He Y, Li B, Li Z, Liu P, Wang Y, Tang Q . Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011; 333(6047):1303-7. PMC: 3462231. DOI: 10.1126/science.1210944. View

17.

Ehrlich M, Gama-Sosa M, Huang L, Midgett R, KUO K, McCune R . Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 1982; 10(8):2709-21. PMC: 320645. DOI: 10.1093/nar/10.8.2709. View

18.

Dawlaty M, Ganz K, Powell B, Hu Y, Markoulaki S, Cheng A . Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell. 2011; 9(2):166-75. PMC: 3154739. DOI: 10.1016/j.stem.2011.07.010. View

19.

Tollefsbol T, HUTCHISON 3rd C . Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase. J Mol Biol. 1997; 269(4):494-504. DOI: 10.1006/jmbi.1997.1064. View

20.

Lehnertz B, Ueda Y, Derijck A, Braunschweig U, Perez-Burgos L, Kubicek S . Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003; 13(14):1192-200. DOI: 10.1016/s0960-9822(03)00432-9. View